NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional) | RFA DK 20 002

Opportunity Information: Apply for RFA DK 20 002

The NIDDK Centers for Diabetes Translation Research (CDTR) grant opportunity (RFA-DK-20-002) is a discretionary NIH center grant (P30; clinical trial optional) intended to build or support institutional centers that can speed up real-world impact from diabetes research. The focus is on T2 to T4 translational research, meaning work that moves evidence from clinical and bedside findings into routine clinical practice, health systems, and community settings, including dissemination and implementation research. The overall goal is to improve population health by accelerating innovation in how diabetes prevention and care strategies are delivered, adopted, sustained, and scaled.

A central expectation of the program is that applicants propose a CDTR structured around shared cores and services rather than a collection of unrelated projects. These cores are meant to provide specialized expertise, tools, training, methods support, and other infrastructure that investigators can use to be more productive and collaborative. The center model is designed to create synergy across funded investigators by making key resources available in a coordinated, cost-effective way and by encouraging cross-cutting methods and novel ideas that would be difficult for individual labs or projects to build alone.

A major emphasis of the FOA is health equity and the reduction of diabetes-related health disparities. Applications are encouraged to incorporate novel methods and research approaches that directly address inequities in diabetes outcomes and care. The announcement also allows for innovative cores that improve broader person-centered, community, or population health outcomes, as long as the applicant clearly explains how the resulting strategies, findings, or tools could be adapted in ways that meaningfully inform disparity-reduction efforts. In practice, this points applicants toward approaches that consider real-world barriers such as access to care, structural and social determinants of health, cultural tailoring, implementation in resource-limited settings, and sustainability across diverse populations.

The FOA expects a strong scientific base anchored in an academic institution and supported by a network of diverse collaborators. Examples of partners specifically noted include healthcare systems, community-based organizations, health departments, and human services organizations. This reflects a core premise of T2-T4 translation: improving diabetes outcomes at scale usually requires collaboration across clinical settings, public health infrastructure, and community institutions that influence patient engagement, service delivery, and long-term maintenance of evidence-based interventions.

Eligibility is broad across U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education when applicable under those categories); for-profit organizations (other than small businesses); small businesses; and other organizations. The FOA also highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

Foreign participation is explicitly restricted. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by NIH policy) are not allowed under this opportunity. In other words, the proposed center and its supported infrastructure must be fully domestic in scope and operations.

Administrative details provided in the source data indicate the sponsoring agency is the National Institutes of Health (specifically NIDDK), the CFDA number is 93.847, and the activity category is listed under food and nutrition and health. The FOA was created on 2020-05-20 with an original closing date of 2020-10-20. The award ceiling and expected number of awards are not specified in the provided listing.

• The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
• This funding opportunity was created on 2020-05-20.
• Applicants must submit their applications by 2020-10-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DK 20 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: